Mutation testing, now routinely accessible for many of the higher than genes, has indicated that germline mutations are chargeable for 30% or maybe more of all pheochromocytomas—nicely in surplus of The ten% of tumors previously regarded as hereditary. Between 12% and 24% of tumors without hav